Human Drugs

× UPDATE! Updated as of 11 November 2024.
 
Product Information
Registration Number
Generic Name
Brand Name
Dosage Strength
Dosage Form
Pharmacologic Category
Manufacturer
Country of Origin
Application Type
Issuance Date
Expiry Date
View DRP-3264-14 Paracetamol/ Vitamin B1/ Vitamin B6/ Vitamin B12 None 500 mg/50 mg/100 mg/100 mcg Film-Coated Tablet Analgesic Lloyd Laboratories, Inc. Philippines CLIDP Conversion 27 May 2024 20 May 2027
View DRP-3264-15 Paracetamol/ Vitamin B1/ Vitamin B6/ Vitamin B12 Pain B-Gan 500 mg/50 mg/100 mg/100 mcg Film-Coated Tablet Analgesic Lloyd Laboratories, Inc. Philippines CLIDP Conversion 27 May 2024 20 May 2027
View DRP-4838-10 Fenofibrate Fenolizen 200 mg Capsule Lipid Modifying Agent (Fibrates) Azarias Pharmaceutical Laboratories Inc. Philippines CLIDP Conversion 30 May 2024 16 October 2028
View DRP-5240-26 Ceftriaxone (as sodium) Ceftratech 1 g Powder for Injection (IM/IV) Antibacterial (Cephalosporin) Scott-Edil Advance Research Laboratories & Education Ltd India CLIDP Conversion 27 May 2024 07 April 2029
View DRP-5411-01 Fluticasone Propionate Flutilon 500 mcg/mL (0.05% w/v) 50 mcg per actuation Suspension for Nasal Spray Corticosteroid Norris Medicines Limited India Renewal 31 May 2024 01 August 2029
View DRP-5486-05 Albendazole Albendix 400 mg Chewable Tablet Antihelmintic (Benzimidazole derivative) Scott-Edil Pharmacia Limited India Renewal 29 September 2024 27 August 2029
View DRP-5683-25 Cefixime None 20mg/mL Granules for Suspension (Oral Drops) Antibacterial J.M. Tolmann Laboratories Inc. Philippines CLIDP Conversion 31 May 2024 20 February 2029
View DRP-6651-04 Rosuvastatin (as Calcium) Rostar 5 mg Film-Coated Tablet Lipid Modifying Agent (HMG CoA Reductase Inhibitor) Maple Pharmaceuticals (Pvt.) Ltd. Pakistan CLIDP Conversion 30 May 2024 22 April 2026
View DRP-6729-04 Risperidone Risperi 2 mg Tablet Antipsychotic LIFESQUARE LABORATORIES INC. Philippines CLIDP Conversion 24 May 2024 20 June 2029
View DRP-8747-03 Omeprazole (as sodium) Promezol 40 mg Lyophilized Powder for Intravenous Injection / Infusion Proton Pump Inhibitor Reyoung Pharmaceutical Co., Ltd. China CLIDP Conversion 30 May 2024 21 February 2025
View DRP-8859-01 Irinotecan Hydrochloride Ventera 20 mg/mL Solution for IV Infusion Antineoplastic agent Qilu Pharmaceutical Hainan Co., Ltd. China CLIDP Conversion 30 May 2024 02 July 2025
View DRP-9341-03 Ampicillin (as Sodium) + Sulbactam (as Sodium) Haitam 500mg/250 mg Powder for Injection (I.M./I.V.) Antibacterial (Penicillin) + Beta-lactamase Inhibitor Reyoung Pharmaceutical Co., Ltd. China CLIDP Conversion 28 June 2024 11 March 2029
View DRP-15188 Iopamidol Pamidol 300 612.4 mg/mL (Equivalent to 300 mg Iodine) Solution for Injection Contrast Media Unique Pharmaceutical Laboratories (A Division of J.B. Chemicals & Pharmaceuticals Ltd.) India Initial 22 May 2024 22 May 2029
View DRP-15186 Ceftazidime (as pentahydrate) with sodium carbonate Brizamide 1 g Powder for Injection (IM/IV) Antibacterial (Third-Generation Cephalosporin) Chengdu Brilliant Pharmaceutical Co., Ltd. China Initial 22 May 2024 22 May 2029
View DRP-15187 Ceftriaxone (as sodium) Axonedu 500 mg Powder for Injection (IM/IV) Antibacterial (Third-generation Cephalosporin) Chengdu Brilliant Pharmaceutical Co., Ltd. China Initial 22 May 2024 22 May 2029
View DRP-15189 Allopurinol Urisol 100 mg Tablet Antigout Centurion Laboratories Pvt. Ltd. India Initial 22 May 2024 22 May 2029
View DR-XY49088 Apixaban Apiban 5 5 mg Film-Coated Tablet Antithrombotic Agent MSN Laboratories Private Limited India Initial 22 May 2024 22 May 2029
View DR-XY49089 Trimetazidine dihydrochloride Trimet PR-80 80 mg Prolonged-Release Capsule Anti-angina (Cardiac Preparation) Globela Pharma Private Limited India Monitored Release (MR) 22 May 2024 22 May 2029
View DRP-15201 Rabeprazole sodium Rabb-20 20 mg Lyophilized Powder for Injection (I.V.) Proton Pump Inhibitor United Biotech Pvt. Ltd. India Initial 24 May 2024 24 May 2029
View DRP-15204 Enalapril maleate Enaprinova-5 5 mg Tablet Angiotensin-converting Enzyme (ACE) Inhibitor S Kant Healthcare Ltd. India Initial 24 May 2024 24 May 2029